18 marzo 2000 anni - Whelan
Descrizione:
Can PMRT improve survival even further if the risk of dying from micrometastatic disease is minimized through the use of systemic therapy?
* reduced LRF by 75%
* improved OS by 17%
Metaanalysis of 18 PMRT trials
Aggiunto al nastro di tempo:
PMRT
Data:
